Lexaria Bioscience Corp. Cash And Cash Equivalents At Carrying Value

Quick Answer

Lexaria Bioscience Corp. reported Cash And Cash Equivalents At Carrying Value of $5.81 million for the year ending 2022.

  • Lexaria Bioscience Corp. showed a decrease of -46.8% in Cash And Cash Equivalents At Carrying Value from 2021 to 2022.
  • This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on November 28, 2022.
  • XBRL data for this metric is available from 2009 to 2022 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2012: $120.6 thousand | Q3 2012: $16.4 thousand | Q4 2012: $180.5 thousand | Q1 2013: $38.9 thousand | Q2 2013: $44.5 thousand | Q3 2013: $27.5 thousand | Q4 2013: $65.5 thousand | Q4 2013: $125.2 thousand | Q1 2014: $28.7 thousand | Q1 2014: $36.9 thousand | Q2 2014: $951.7 thousand | Q2 2014: $877.9 thousand | Q3 2014: $578.5 thousand | Q4 2014: $431.1 thousand | Q1 2015: $792.0 thousand | Q2 2015: $832.1 thousand | Q4 2015: $84.0 thousand | Q1 2016: $40.2 thousand | Q2 2016: $37.1 thousand | Q4 2016: $124.2 thousand | Q1 2017: $523.6 thousand | Q2 2017: $2.79 million | Q4 2017: $2.21 million | Q1 2018: $2.32 million | Q2 2018: $2.06 million | Q4 2018: $2.64 million | Q1 2019: $2.00 million | Q2 2019: $2.00 million | Q4 2019: $1.33 million | Q1 2020: $740.0 thousand | Q2 2020: $2.03 million | Q3 2020: $1.29 million | Q4 2020: $525.3 thousand | Q1 2021: $9.35 million | Q2 2021: $8.11 million | Q4 2021: $9.68 million | Q1 2022: $8.36 million | Q2 2022: $7.05 million | Q3 2022: $5.81 million | Q4 2022: $4.53 million | Q1 2023: $3.27 million.
  • Over the full 15 years of available data (2009 to 2022), Lexaria Bioscience Corp.'s Cash And Cash Equivalents At Carrying Value has grown by 1,660.7%.
  • Historical annual values: Fiscal year 2022: $5.81 million | Fiscal year 2021: $10.92 million | Fiscal year 2020: $1.29 million | Fiscal year 2019: $1.29 million | Fiscal year 2018: $1.73 million | Fiscal year 2017: $2.53 million | Fiscal year 2016: $93.4 thousand | Fiscal year 2015: $260.1 thousand | Fiscal year 2014: $703.0 thousand | Fiscal year 2013: $65.5 thousand | Fiscal year 2013: $65.5 thousand | Fiscal year 2012: $180.5 thousand | Fiscal year 2011: $31.2 thousand | Fiscal year 2010: $63.0 thousand | Fiscal year 2009: $330.2 thousand.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: